Share-based Payment Arrangement, Expense of Prestige Consumer Healthcare Inc. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prestige Consumer Healthcare Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • Prestige Consumer Healthcare Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,767,000, a 17% decline year-over-year.
  • Prestige Consumer Healthcare Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,047,000, a 5.9% decline year-over-year.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2024 was $11,157,000, a 20% decline from 2023.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14,010,000, a 13% increase from 2022.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12,405,000, a 37% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Prestige Consumer Healthcare Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,047,000 $1,767,000 -$367,000 -17% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q2
Q2 2025 $11,414,000 $3,682,000 +$257,000 +7.5% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 $11,157,000 $2,733,000 -$994,000 -27% 01 Jan 2025 31 Mar 2025 10-K 09 May 2025 2025 FY
Q4 2024 $12,151,000 $2,865,000 +$416,000 +17% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 $11,735,000 $2,134,000 -$1,554,000 -42% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2026 Q2
Q2 2024 $13,289,000 $3,425,000 -$721,000 -17% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q1 2024 $14,010,000 $3,727,000 +$1,078,000 +41% 01 Jan 2024 31 Mar 2024 10-K 09 May 2025 2025 FY
Q4 2023 $12,932,000 $2,449,000 +$16,000 +0.66% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025 2025 Q3
Q3 2023 $12,916,000 $3,688,000 +$222,000 +6.4% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 $12,694,000 $4,146,000 +$289,000 +7.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2025 Q1
Q1 2023 $12,405,000 $2,649,000 +$941,000 +55% 01 Jan 2023 31 Mar 2023 10-K 09 May 2025 2025 FY
Q4 2022 $11,464,000 $2,433,000 +$199,000 +8.9% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024 2024 Q3
Q3 2022 $11,265,000 $3,466,000 +$247,000 +7.7% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2024 Q2
Q2 2022 $11,018,000 $3,857,000 +$1,979,000 +105% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2024 Q1
Q1 2022 $9,039,000 $1,708,000 -$891,000 -34% 01 Jan 2022 31 Mar 2022 10-K 15 May 2024 2024 FY
Q4 2021 $9,930,000 $2,234,000 +$646,000 +41% 01 Oct 2021 31 Dec 2021 10-Q 02 Feb 2023 2023 Q3
Q3 2021 $9,284,000 $3,219,000 +$327,000 +11% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2023 Q2
Q2 2021 $8,957,000 $1,878,000 +$414,000 +28% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2023 Q1
Q1 2021 $8,543,000 $2,599,000 +$1,380,256,000 01 Jan 2021 31 Mar 2021 10-K 05 May 2023 2023 FY
Q4 2020 $1,371,713,000 $1,588,000 -$192,000 -11% 01 Oct 2020 31 Dec 2020 10-Q 03 Feb 2022 2022 Q3
Q3 2020 $1,371,521,000 $2,892,000 +$371,000 +15% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2022 Q2
Q2 2020 $1,371,892,000 $1,464,000 -$1,379,536,000 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2022 Q1
Q1 2020 $7,644,000 $1,377,657,000 -$1,378,795,000 -121159% 01 Jan 2020 31 Mar 2020 10-K 06 May 2022 2022 FY
Q4 2019 $1,386,439,000 $1,780,000 -$120,000 -6.3% 01 Oct 2019 31 Dec 2019 10-Q 04 Feb 2021 2021 Q3
Q3 2019 $1,386,559,000 $2,521,000 -$179,000 -6.6% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2021 Q2
Q2 2019 $1,386,738,000 $1,381,000,000* +$1,379,300,000 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q1
Q1 2019 $7,438,000 $1,138,000 -$871,000 -43% 01 Jan 2019 31 Mar 2019 10-K 07 May 2021 2021 FY
Q4 2018 $8,309,000 $1,900,000 -$300,000 -14% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020 2020 Q3
Q3 2018 $8,609,000 $2,700,000 -$300,000 -10% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2020 Q2
Q2 2018 $8,909,000 $1,700,000 $0 0% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2020 Q1
Q1 2018 $8,909,000 $2,009,000 +$161,000 +8.7% 01 Jan 2018 31 Mar 2018 10-K 08 May 2020 2020 FY
Q4 2017 $8,748,000 $2,200,000 -$200,000 -8.3% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q3
Q3 2017 $8,948,000 $3,000,000 +$1,000,000 +50% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2019 Q2
Q2 2017 $7,948,000 $1,700,000 -$200,000 -11% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2019 Q1
Q1 2017 $8,148,000 $1,848,000 -$1,006,000 -35% 01 Jan 2017 31 Mar 2017 10-K 13 May 2019 2019 FY
Q4 2016 $9,154,000 $2,400,000 +$300,000 +14% 01 Oct 2016 31 Dec 2016 10-Q 01 Feb 2018 2018 Q3
Q3 2016 $8,854,000 $2,000,000 $0 0% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2018 Q2
Q2 2016 $8,854,000 $1,900,000 -$1,100,000 -37% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2018 Q1
Q1 2016 $9,954,000 $2,854,000 +$836,000 +41% 01 Jan 2016 31 Mar 2016 10-K 10 May 2018 2018 FY
Q4 2015 $9,118,000 $2,100,000 +$600,000 +40% 01 Oct 2015 31 Dec 2015 10-Q 02 Feb 2017 2017 Q3
Q3 2015 $8,518,000 $2,000,000 +$500,000 +33% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2017 Q2
Q2 2015 $8,018,000 $3,000,000 +$1,100,000 +58% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2017 Q1
Q1 2015 $6,918,000 $2,018,000 01 Jan 2015 31 Mar 2015 10-K 17 May 2017 2017 FY
Q4 2014 $1,500,000 +$200,000 +15% 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q3
Q3 2014 $1,500,000 +$200,000 +15% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2016 Q2
Q2 2014 $1,900,000 +$700,000 +58% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2016 Q1
Q4 2013 $1,300,000 +$300,000 +30% 01 Oct 2013 31 Dec 2013 10-Q 05 Feb 2015 2015 Q3
Q3 2013 $1,300,000 +$200,000 +18% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2015 Q2
Q2 2013 $1,200,000 +$300,000 +33% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2015 Q1
Q4 2012 $1,000,000 +$300,000 +43% 01 Oct 2012 31 Dec 2012 10-Q 07 Feb 2014 2013 Q3
Q3 2012 $1,100,000 +$300,000 +38% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q2
Q2 2012 $900,000 $0 0% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013 2013 Q1
Q4 2011 $700,000 01 Oct 2011 31 Dec 2011 10-Q 07 Feb 2013 2012 Q3
Q3 2011 $800,000 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012 2012 Q2
Q2 2011 $900,000 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q1

Prestige Consumer Healthcare Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,157,000 -$2,853,000 -20% 01 Apr 2024 31 Mar 2025 10-K 09 May 2025 2025 FY
2023 $14,010,000 +$1,605,000 +13% 01 Apr 2023 31 Mar 2024 10-K 09 May 2025 2025 FY
2022 $12,405,000 +$3,366,000 +37% 01 Apr 2022 31 Mar 2023 10-K 09 May 2025 2025 FY
2021 $9,039,000 +$496,000 +5.8% 01 Apr 2021 31 Mar 2022 10-K 15 May 2024 2024 FY
2020 $8,543,000 +$899,000 +12% 01 Apr 2020 31 Mar 2021 10-K 05 May 2023 2023 FY
2019 $7,644,000 +$206,000 +2.8% 01 Apr 2019 31 Mar 2020 10-K 06 May 2022 2022 FY
2018 $7,438,000 -$1,471,000 -17% 01 Apr 2018 31 Mar 2019 10-K 07 May 2021 2021 FY
2017 $8,909,000 +$761,000 +9.3% 01 Apr 2017 31 Mar 2018 10-K 08 May 2020 2020 FY
2016 $8,148,000 -$1,806,000 -18% 01 Apr 2016 31 Mar 2017 10-K 13 May 2019 2019 FY
2015 $9,954,000 +$3,036,000 +44% 01 Apr 2015 31 Mar 2016 10-K 10 May 2018 2018 FY
2014 $6,918,000 01 Apr 2014 31 Mar 2015 10-K 17 May 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.